Wei‐Yu Kao

1.9k total citations
68 papers, 1.2k citations indexed

About

Wei‐Yu Kao is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Wei‐Yu Kao has authored 68 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 40 papers in Hepatology and 13 papers in Surgery. Recurrent topics in Wei‐Yu Kao's work include Liver Disease Diagnosis and Treatment (36 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers) and Hepatitis B Virus Studies (15 papers). Wei‐Yu Kao is often cited by papers focused on Liver Disease Diagnosis and Treatment (36 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers) and Hepatitis B Virus Studies (15 papers). Wei‐Yu Kao collaborates with scholars based in Taiwan, United States and United Kingdom. Wei‐Yu Kao's co-authors include Chien‐Wei Su, Han‐Chieh Lin, Jaw‐Ching Wu, Teh‐Ia Huo, Yi‐Hsiang Huang, Jaw‐Ching Wu, Chun‐Chao Chang, Shou‐Dong Lee, Cheng‐Yuan Hsia and Yi‐Hong Chou and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Wei‐Yu Kao

61 papers receiving 1.2k citations

Peers

Wei‐Yu Kao

HEPAT

EPIDE

SURGE

ONCOL

Yuan‐Hung Kuo Taiwan

Yong Jin Jung South Korea

Nobuyuki Toshikuni Japan

Hemda Schmilovitz‐Weiss Israel

Martin F. Sprinzl Germany

Ming‐Chao Tsai Taiwan

Yoshitaka Takuma Japan

Tsung‐Han Wu Taiwan

Hiroyasu Morikawa Japan

Ju Hyun Kim South Korea

Yuan‐Hung Kuo Taiwan

Wei‐Yu Kao

706 ×0.8

HEPAT

634 ×0.8

EPIDE

407 ×1.4

SURGE

168 ×0.9

ONCOL

72 ×0.6

Citations per year, relative to Wei‐Yu Kao Wei‐Yu Kao (= 1×) peers Yuan‐Hung Kuo

Countries citing papers authored by Wei‐Yu Kao

Since Specialization

Citations

This map shows the geographic impact of Wei‐Yu Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Yu Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Yu Kao more than expected).

Fields of papers citing papers by Wei‐Yu Kao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Yu Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Yu Kao. The network helps show where Wei‐Yu Kao may publish in the future.

Co-authorship network of co-authors of Wei‐Yu Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Yu Kao. A scholar is included among the top collaborators of Wei‐Yu Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Yu Kao. Wei‐Yu Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Sandy Huey-Jen, et al.. (2025). Cross-ancestry discovery of genetic risk variants for lean metabolic dysfunction-associated steatotic liver disease. Cell & Bioscience. 15(1). 131–131.

Su, Tung‐Hung, Sheng‐Shun Yang, Mei–Hsuan Lee, et al.. (2025). High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology. 31(3). 796–809. 1 indexed citations

Kao, Wei‐Yu, et al.. (2025). Plasmon-activated water innovatively applicable for improving the performance of surface-enhanced Raman scattering. Talanta. 295. 128232–128232. 1 indexed citations

Chang, Yu‐Ping, Ji‐Yuh Lee, Chi‐Yi Chen, et al.. (2025). Predictive Value of Serum Mac‐2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus–Infected Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease. Journal of Gastroenterology and Hepatology. 41(1). 322–331.

Wu, Ming‐Shun, Wei‐Yu Kao, Shih–Jer Hsu, et al.. (2025). Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation. Liver Cancer. 15(1). 149–164.

Jeong, Sohyun, Yao‐Kuang Wang, I‐Chen Wu, et al.. (2024). Microbiome signatures associated with clinical stages of gastric Cancer: whole metagenome shotgun sequencing study. BMC Microbiology. 24(1). 139–139. 5 indexed citations

Kao, Wei‐Yu, et al.. (2024). More-energetic vapors of in situ plasmon-activated water as an environmentally friendly etchant. Journal of Industrial and Engineering Chemistry. 140. 215–224. 1 indexed citations

Tan, Elise Chia‐Hui, Wei‐Yu Kao, Pei‐Chang Lee, et al.. (2024). The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy. Journal of Gastroenterology and Hepatology. 39(10). 2077–2087. 1 indexed citations

Liu, Chen‐Hua, Yu‐Ping Chang, Ji‐Yuh Lee, et al.. (2024). Four weeks of off‐treatment follow‐up is sufficient to determine virologic responses at off‐treatment week 12 in patients with hepatitis C virus infection receiving fixed‐dose pangenotypic direct‐acting antivirals. Journal of Medical Virology. 96(5). e29675–e29675. 2 indexed citations

10.

Kao, Wei‐Yu, Elise Chia‐Hui Tan, Hsin‐Lun Lee, et al.. (2023). Entecavir versus tenofovir on prognosis of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy. Alimentary Pharmacology & Therapeutics. 57(11). 1299–1312. 8 indexed citations

11.

Wang, Weu, Ching-Wen Chang, I‐Wei Chang, et al.. (2023). Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients. Journal of Clinical Medicine. 12(11). 3730–3730. 3 indexed citations

12.

Chang, Chun‐Chao, Chih‐Yi Liu, Yuarn‐Jang Lee, et al.. (2022). Functional Plasmon-Activated Water Increases Akkermansia muciniphila Abundance in Gut Microbiota to Ameliorate Inflammatory Bowel Disease. International Journal of Molecular Sciences. 23(19). 11422–11422. 12 indexed citations

13.

Liu, Chen‐Hua, Hsin‐Yun Sun, Cheng‐Yuan Peng, et al.. (2022). Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study. Open Forum Infectious Diseases. 9(8). ofac348–ofac348. 10 indexed citations

14.

Chang, Chun‐Chao, Jui‐Hsiang Tang, Wei‐Yu Kao, et al.. (2021). Lightweight deep neural networks for cholelithiasis and cholecystitis detection by point-of-care ultrasound. Computer Methods and Programs in Biomedicine. 211. 106382–106382. 20 indexed citations

15.

Chiou, Yi‐You, Nai‐Chi Chiu, Chien-An Liu, et al.. (2020). Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation. Scientific Reports. 10(1). 2006–2006. 10 indexed citations

16.

Kao, Wei‐Yu, I‐Wei Chang, Chi‐Long Chen, et al.. (2020). Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. Obesity Surgery. 30(4). 1249–1257. 18 indexed citations

17.

Kao, Wei‐Yu, Chien‐Wei Su, Elise Chia‐Hui Tan, et al.. (2018). Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C. Hepatology. 69(3). 1151–1164. 24 indexed citations

18.

Kao, Wei‐Yu, Yee Chao, Chun‐Chao Chang, et al.. (2015). Prognosis of Early-Stage Hepatocellular Carcinoma. Medicine. 94(43). e1929–e1929. 32 indexed citations

19.

Hung, Hung-Hsu, Hao-Jan Lei, Gar-Yang Chau, et al.. (2012). Milan Criteria, Multi-nodularity, and Microvascular Invasion Predict the Recurrence Patterns of Hepatocellular Carcinoma After Resection. Journal of Gastrointestinal Surgery. 17(4). 702–711. 28 indexed citations

20.

Kao, Wei‐Yu, Hung-Hsu Hung, Han‐Chieh Lin, et al.. (2010). Hepatocellular Carcinoma With Presentation of Budd-Chiari Syndrome. Journal of the Chinese Medical Association. 73(2). 93–96. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact